Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes
Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes
Recruiting · NCT06706284 · Registry updated 2026-10-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes | Nutritional and Metabolic Diseases, central nervous system disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, injury, metabolic disease, nervous system disorder, nervous system injury, spinal cord disorder, spinal cord injury, type 2 diabetes mellitus | Recruiting | Phase 4 | 2026-10-05 | NCT06706284 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Marzieh Salehi | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 617 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University Health - Texas Diabetic Institute | San Antonio | United States | 1 |
| University of Texas Health Science Center at San Antonio | San Antonio | United States | 193 |